Hyaluronan, a glycosaminoglycan, abundant in the tumour microenvironment, is a key player in many processes associated with cancer.
Introduction
Cancer in humans is very common with a third of us developing 15 some form of it during our lifetime. However a number of animal species have been described to have either a very low incidence or resistance to cancer. 1 This can usually be attributed to extra tumour suppressive cell signalling pathways, however there is one exception. The naked mole rat is a remarkable creature in that it 20 has an exceptionally long life span for its size and is resistant to cancer. 2 Thus when a breakthrough paper was published attributing the naked moles cancer resistant to the production of an ultra-high molecular weight glycosaminoglycan 3 , the inevitable wild speculation, regarding injecting humans with this as a 25 preventative measure against future development of cancer was brandished. It turns out that this molecule, albeit in a lower molecular weight form, is a ubiquitous extracellular matrix (ECM) molecule in humans, and has been attributed to play important roles in many 30 aspects of cancer pathology. [4] [5] [6] [7] [8] [9] [10] These roles can be roughly split into two categories, although there is obvious crossover. The first is biological in nature, involving the binding of hyaluronan with cell membrane based receptors to initiate signalling and subsequent gene expression. The second is mechanical, relating to 35 purely physical interactions regulating cell adhesion, mobility and invasion. The cancer cell microenvironment comprises non-cancerous cells, ECM biomolecules and vasculature. Cues within the microenvironment can regulate the various processes involved in 40 cancer progression.
11 Within the microenvironment the ECM, a "glue like" substance, has an intricate relationship with the cells in which it encloses. 5,12-14 Abnormality of the ECM within the microenvironment is a characteristic of cancer, and abnormal levels of hyaluronan within the ECM are indicative of a poor 45 prognosis for the patient. [15] [16] [17] [18] [19] [20] . A symbiotic relationship exists whereby tumour cells have the ability to remodel the ECM around them, and the matrix has the ability to affect the behaviour of the tumour cells. [21] [22] [23] [24] Soft matter properties of the matrix are an important factor in the mechanotransduction between these two 50 environments. 25 A second hyaluronan rich interface exists called the pericellular matrix. This micron thick cell coating can also play an important role in the cell mobility necessary for metastatic spread . 26 A somewhat confusing paradox exists in that the presence of 55 hyaluronan has been attributed to cancer resistance in the naked mole rat, whereas the presence of hyaluronan in human malignancies is seen as an indicator of poor prognosis. However in the human case the hyaluronan has been cleaved into fragments of varying molecular weights, which themselves may have disruptive 60 effects on cell/microenvironment linkages. 27, 28 Given this strong link between hyaluronan abundance/abnormality in cancer, an opportunity exists to target hyaluronan in the microenvironment. 29, 30 Such an extra line of attack is particularly attractive in cancers that have been hard to treat with conventional unit, which is composed of N-acetyl-glucosamine and glucoronic acid. Depending on function and location, its molecular weight (in humans) can vary between 0.5 to 2 MDa. [33] [34] [35] This compares with naked mole rat hyaluronan (NMR-HA) which varies from 6 to 12 MDa. 3 The molecular weight of this biopolymer determines its 5 physicochemical properties and these determine its function. 36 In contrast to most other glycosaminoglycans which are produced in the Golgi apparatus and attached to other proteins, HA is synthesised in the inner cell membrane and extrudes out of the cell surface as further polymer units are added, 7,37 ( Fig.1) the cell is fundamental to many aspects of cancer pathology. The balance between hyaluronan production and destruction may be key to understanding this role.
Interaction with cell membrane receptors 35 Beyond the oncological event that transforms a cell into malignancy, the processes involved in cancer progression have both biological and mechanical origins. HA interacts with cells though transmembrane receptors, the main such receptor being CD44 40, 41 , (Fig.1) . It is these linkages and others like these, that 40 regulate the adhesion and mobility of cells. [42] [43] [44] There are of course other ECM-cell interactions [45] [46] [47] for example those involving the protein fibronectin and the cell surface receptor integrin. 48 The complex interactions between CD44 and HA have received intensive investigation including the role for membrane bound 45 enzymes, which can cleave the CD44/HA complex and therefore facilitate cancer cell invasion.
49 Fig. 2 shows how a cancerous cell in a human can break through an HA rich matrix and invade into a blood vessel via remodelling of its ECM. Enzymes degrading the HA and enzymes cleaving the CD44 receptor create a path for cell 50 movement.
Fig. 2
Remodelling of the hyaluronan rich matrix by cancer cells leading to invasion. In healthy cells CD44 receptors bind to hyaluronan in the matrix.
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Cancerous cells over express the membrane bound enzymes MMPs which cleave CD44 receptors. They also over produce the enzyme hyaluronidase which digests hyaluronan into smaller fragments. In this way the cancer cells can "break" through the matrix and invade into the circulatory system.
60

Soft Matter Properties of HA
Given the importance of intermolecular and mechanical interactions both within the ECM and with the cell membrane, understanding the soft matter properties of HA is critical to 65 determining its biological function. These can be examined at both the gross and microscopic levels. A particular characteristic of HA containing solutions are their high viscosity 50 and their ability to form cross-linked networks. 51 This coupled with HA's ability to form gel like structures has been linked to increased density and and adhesion is prevented, thus proving the importance of this interaction in phenomena related to metastatsis. [56] [57] [58] The nature of this ligand receptor linkage is force dependent, meaning it has the ability to regulate cell rolling via force induced conformational changes in the CD44.
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Much can be learnt about the mechanics and assembly of HA when examined at the single molecule level. Atomic force microscopy (AFM) reveals that HA can adopt a number of different conformations when adsorbed onto surfaces. In tapping mode, AFM reveals branched structures for high molecular weight HA
15
with both intramolecular and intermolecular interactions. 60, 61 Force spectroscopy, the unfolding of single biomolecules with an AFM tip, has shown HA to exhibit hydrogen bonding networks in aqueous solutions 62 with the molecules undergoing a non-random to random coil transition upon heating to 46 °C. and Ssingle
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molecule stretching using an optical trap has allowed the measurement of persistence length, a measure of molecular stiffness, to be established. 63 This was found to be 4.5 ± 1.2 nm, indicative of a single molecule measurement. However given the tendency of HA to form branched and network structures a more 25 useful quantity would that be the persistence length of higher order fibrous structures. Force spectroscopy has also measuredquantified the tensile strength of the CD44-HA bond. 64 These single molecule measurements revealed a rupture force of between 70 and 80 pN depending on contact duration. For 30 comparison these were significantly higher than the rupture strength of the CD44 -fibrinogen bond. Extending this methodology further by attaching HA molecules to an AFM cantilever, it has been possible to examine the forces of interaction between HA and live glioma cells. 65 As well as binding with CD44 35 and other membrane based receptors, HA can interact directly with lipids. 66 Evidence for these non -specific interactions have been observed in the interaction of HA with liposomes, giving rise to cylinder and sheet like super structures . 67 It has also been proposed that hydrophyllic regions of HA could attract the polar head groups 40 of phospholipids 68 , a phenomenon which could explain the association of hayaluronanHA with cell membranes and by extension tumour cell membranes. Using soft matter approaches to assemble model systems can help deconvolute physical interactions from biological. This has been 45 achieved by reconstituting CD44 receptors into lipid bilayers, allowing HA adsorption behaviour to be studied using techniques such as the quartz crystal microbalance and ellipsometry. 69 Mechanical stress generated in a confining matrix has been shown to control tumour spheroid shape and morphology. 70 A logical 50 inference from this observation is that the material constituents of the ECM can influence the growth behaviour of a tumour. It is one thing measuring the mechanics/material properties of ECM components but novel approaches are required to study the material properties of HA in the pericellular matrix (PCM), the 
Elevated levels of hyaluronan
A paradox exists between the high levels of HA found in the naked mole rat, the presence of which is attributed to the prevention of cancer, and the high levels of HA associated with cancerous tissues in humans, an indicator of poor prognosis. In order to understand 75 this fundamental issue one must consider what causes an accumulation of HA in human tumours. In healthy tissue there is a balance between HA synthesis and its degradation. For the naked mole rat HA is of the ultra-high molecular weight variety, whereas in human cancers, the molecular weight is much lower. In some 80 cancers (squamous cell carcinoma and melanoma), HA levels overall are low and linked to metastatic potential 72, 73 , whereas in other cancers such as breast 74 and lung adenocarcinomas 75 , HA accumulation is high, but clinical outcomes are still poor. 76, 77 The levels of HA are assessed using histochemical staining. For and metastasis. 78 The second is that there are particular cancer cells that can overexpress HA in response to chemotherapy, thereby producing a protective effect for the tumour. 79 A further concept is that the presence of large amounts of HA can prevent chemotherapeutic agents accessing the cancer cells. 80 In order to 100 illustrate the first theory, Fig. 4 presents a magnetic resonance image (MRI) of a large malignant tumour in the thigh of a patient subsequently diagnosed with a sarcoma. Sarcomas are rare cancers arising in the connective tissues and usually appear in the limbs. Alongside the MRI is the pathology slide from the tumour. The 105 lighter grey colour of the tumour in the MRI is due to the large numbers of rapidly dividing cancer cells and the relatively high glycosaminoglycan content, mainly HA, in the ECM. 81 The cells in the pathology image are stained for a matrix metalloproteinase enzyme which cleaves the HA receptor CD44. In this tumour there is intense MMP staining because the cells are constantly destroying their microenvironment using these enzymes to cleave key ECM components such as collagen and HA. This HA release via initial cleavage of the CD44/HA complex followed by further HA breakdown into smaller fragments will further promote the metastasis of cancer cells via the facilitation of cancer cell 10 migration. 37 Moreover it has been demonstrated that the HA fragments themselves can begin a positive feedback loop whereby their very presence increases production of CD44 cleaving enzymes.
82,83 Abundance of HA in tumours has been found to have serious implications in the delivery of therapy. Such HA related resistance 25 is usually cancer and drug dependent. Examples include resistance to Adriamycin in head and neck cancer, 84 and resistance to Carboplatin in ovarian cancer, 79 In terms of more recent treatment strategies which include utilisation of antibodies to perturb cancer function, the accumulation of HA in solid tumours can act as a 30 barrier to monoclonal antibody therapy. 85 In order to mitigate these effects, it has been shown that it is possible to minimise drug resistance in peripheral nerve sheath tumours by disrupting the CD44-HA bond. 86 This disruption was achieved by delivering small oligosaccharides of HA which could compete for the 35 receptor sites with the larger HA polymers. 87 
Hyaluronan based nanoparticle therapy
The use of HA based nanoparticle systems in cancer therapy has several advantages over existing formulations including selective attachment (via the CD44 receptors of the target cells), the fact that 40 many carcinomas over-express CD44, and the ease of chemical functionalisation. 88 With its intricate role in cancer biology, it is of no surprise that HA and the CD44/HA interaction are being targeted as a strategy for both disruption and drug delivery. One such approach has been to 45 load lipid based nanoparticles with HA oligosaccharides with the aim of breaching HA barrier found in breast cancers. The HA oligosaccharides, in essence HA fragments, compete with the native HA for cell surface CD44 receptors. Moreover these oligosaccharide containing particles have the potential to 50 overcome chemoresistance. 89 A related approach has been to graft HA lipid vesicles for the delivery of gene silencing RNA designed to interfere with key cancer cell signalling pathways. The overexpression of CD44 receptors on cancer cells results in HA accumulation which in turn facilitates the internalisation of the HA 55 coated vesicles into the cancer cells. Once internalised, the interfering RNA renders the cancer cell susceptible to chemotherapy. 90 HA coating of lipid vesicles containing chemotherapeutic agents is relatively straight forward if cationic lipids are used. This is because HA has a negative charge and an 60 ionic exchange mechanism can be exploited. Such a strategy was applied to target CD44 positive colon cancer cells. 91 As an alternative to liposome based strategiese HA decorated polymer nanoparticles have been engineered to target CD44 receptors on t malignant cell surfaces with the particles being internalised via 65 receptor mediated endocytosis. 92 Such polymer vesicles make use of the so called enhanced permeability and retention effect to reach the innards of solid tumours. One approach to treating skin cancer involved targeting the HA itself. This was achieved via a nanoformulation of the HA 70 degrading enzyme hyaluronidase. Its modus operandi was to degrade tumour associated HA reducing the gel like properties of the ECM and thus allowing subsequent administration of chemotherapy drugs to reach the tumour. 93 Given the many adverse effects that accumulation of HA has on tumour 75 progression, depleting the tumour of this antagonistic biopolymer presents opportunities for therapy. 87 
HA based hydrogels for studying invasion
Given the role of HA in the ECM, its role in invasion, the process by which cancerous cells break through the extracellular matrix, is 80 directly related to its over-expression. A particularly revealing method to study this phenomenon in vitro has involved biologists adopting soft matter approaches to mimic the tumour microenvironment. 94 Using gels of defined compositions to mimic the tumour ECM, entrapped cells are observed and their 85 trajectories through the gel analysed (Fig. 5) . [95] [96] [97] A prime example are gels used to mimic ECM in the brain where HA is known to play a major role in glioma cell invasion. Rao et al formulated composite HA-collagen gels to examine the behaviour of patient tumour derived glioblastoma cells 98 . They showed that by adding 90 HA they could increase the modulus of pure collagen hydrogels from 300 Pa to greater than 1000 Pa. These gel mechanical properties compare favourably to brain tissue reported to have a modulus of between 200 and 1000 kPa. 99 and Pedron et al demonstrated it was possible to regulate glioma cell phenotype 95 using brain mimetic HA hyrogels. 95, 100 This approach has been generalised to numerous different cancer cell lines allowing a comparative study of invasion and suggest that such gels represent some of the essential features of the ECM. 101 HA in isolation does notn't form robust gels therefore one of two strategies are used to 100 overcome this limitation . The first is chemical modification of hyaluronanHA so that it can form the covalent cross links necessary for gel formation. Methods to create such crosslinkable HA involves targeting either carboxiylic acid or hydroxyl groups.. 102 A second strategy is to combine HA with a component that does readily form robust gels. Collagen is often used for this purpose and has the added value that it is also an extracellular 5 matrix component. 103 Commercially available gels derived from tumour secretions are also useful models and have been utilised to demonstrate that the HA-CD44 interaction facilitates invasion of colon carcinoma cells.
104 These gels also allow the relationship between matrix mechanical properties and cell behaviour to be 10 investigated. For example Shen et al were able to show that the stiffer the HA hydrogel, the less cancer cell invasion was observed. 105 This was highly consistent with the general findings that cells can respond to the stiffness of their ECM. 106 In order to further exploit the soft matter properties of model systems, 15 researchers have attempted to recreate the tumour microenvironment using a combination of lipid bilayerhydrogels, and HA and growth factors. 107 They were able to grow tumouroids from prostate cancer cells and tune the mechanical properties of the gels to simulate the microenvironment. The gels produced had 20 an average modulus of 234 ± 30 Pa and importantly could be degraded by hyaluronidase, the hyaluronanHA digesting enzyme. 
Perspective
Understanding the soft matter properties of hyaluronan in the 35 context of its role in cancer remains a challenge due to both the complexity of biological systems and the disease itself. However simplified model systems such as gels and microfluidic assays can reveal the physics of HA mediated process, many of which are involved in various stages of metastasis. Moreover gels can be 40 tuned to have similar mechanical properties to the extracellular matrix, allowing the effect of mechanics on cell invasion and model tumour growth to be investigated. As these gel based systems become more complex by incorporating additional components of the ECM, the studies will become more accurate in 45 replicating in vivo behaviour. Nanoparticle base formulations exploiting HA-receptor interactions and targeting HA itself offer the potential to modify the tumour microenvironment. This could be advantageous both for disease treatment and reducing tumour resistance to chemotherapy.
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It is obvious that a large gap in knowledge exists in terms of quantifying and physical characterisation of HA from the tumour microenvironment. To date quantification has been performed in a histological sense, rather than a physically accurate method involving polymer physics. This leaves a gap for soft matter 55 scientists to work with clinicians in order to extract and characterise HA from the tumour microenvironment. The mechanisms by which ultra-high molecular weight HA confers its anti-cancer properties in the naked mole rat may involve several different routes, both signal based and physical in origin. research specialises in the soft matter properties of biomolecules, cells and tissue. This can be split into two themes. The first is to better understand disease. The second is to mimic some of the unique properties of biological systems for engineering applications.
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